About Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research
Pioneering pharmaceutical research to improve healthcare outcomes across Lebanon and the Middle East.
Guided by Purpose, Driven by Excellence.
To establish Lebanon as a regional hub for pharmaceutical research and innovation, ensuring that patients across the Middle East have access to safe, effective, and affordable medications.
To conduct high-quality bioequivalence studies that meet international regulatory standards. By fostering collaboration between academia, the pharmaceutical industry, and regulatory authorities, we aim to build confidence in generic medications and contribute to improved healthcare outcomes in Lebanon and beyond.
Part of the LAU Legacy
Clinical and data analysis services are supported by LAU's reputable School of Medicine, School of Pharmacy, School of Nursing, and the LAU Medical Centers (LAU Medical Center-Rizk Hospital and LAU Medical Center-Saint John's Hospital).
The Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research operates within a dynamic ecosystem for research, innovation, and industry collaboration. Clinical and data analysis services are supported by LAU's reputable School of Medicine, School of Pharmacy, School of Nursing, and the LAU Medical Centers (LAU Medical Center-Rizk Hospital and LAU Medical Center-Saint John's Hospital).
State-of-the-Art Facility
Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research facility spans approximately 1,350 square meters across two dedicated floors, purpose-built for pharmaceutical research to the highest international standards.
BioAnalytical Laboratory
Equipped with advanced LC-MS/MS instruments for method development, validation, and sample analysis. Our laboratory follows ICH M10 guidelines for bioanalytical method validation, ensuring data integrity and regulatory compliance.
Clinical Unit
A 42-bed clinical facility designed to accommodate volunteer subjects for bioequivalence studies. The unit includes dedicated spaces for subject monitoring, blood sampling, sample processing, and medical oversight, all compliant with ICH E6 (R2) guidelines for Good Clinical Practice.
Leadership
-

Dr. Moise Khayrallah
On February 27, 2026, Dr. Moise Khayrallah signed a landmark gift agreement with LAU, establishing the endowed fund that supports the center bearing his name, advancing pharmaceutical and medical research for generations to come. -

Dr. Chaouki T. Abdallah
President
Chaouki T. Abdallah became the tenth president of LAU on October 1, 2024. -

Dr. Zeina Khouri-Stevens
Executive Vice President
Dr. Zeina Khouri-Stevens was appointed Executive Vice President for Health Services on July 1, 2025, tasked with strengthening and unifying LAU’s academic health system. -

Sam H. Haidar, Ph.D., R.Ph.
Executive Director
Dr. Haidar is the Executive Director of the Dr. Moise Khayrallah Center for Pharmaceutical and Medical Research. Prior to this appointment, Dr. Haidar served 27 years in different roles within the US FDA, Center for Drug Evaluation and Research
Oversight and Strategy Board
-

Dr. Moise Khayrallah
Donor Representative (Chair)
-

Dr. Zeina Khouri-Stevens
EVP Health Affairs (Vice-Chair)
-

Dr. Elie Badr
VP Business Development and Global Affairs
-

Mrs. Carole Abi Karam
Pharma/CRO Executive
-

Dr. Rita Karam
Regulatory Affairs/Quality Expert
-

Dr. Hady Ghanem
Biomedical/Clinical Research Expert
-

Dr. Joseph Stephan
Legal/Bioethics Expert
-

Dr. Sam Haidar
Khayrallah Center Director
-

Dr. Naser Alsharif
Dean of Pharmacy
-

Dr. Sola Aoun Bahous
Dean of Medicine
-

Dr. Costantine Daher
Dean of Nursing
-

VP Rasha Fadda
-

Mr. Mario Rebeiz
LAU Finance/Grants Representatives